Brokers Offer Predictions for NextPlat Q2 Earnings

NextPlat Corp. (NASDAQ:NXPL) – Litchfield Hills Research issued their Q2 2026 earnings per share estimates for shares of NextPlat in a research report issued on Wednesday, June 24th. Litchfield Hills Research analyst T. O’neill forecasts that the company will earn ($0.21) per share for the quarter. Litchfield Hills Research currently has a “Buy” rating and a $11.00 target price on the stock. Litchfield Hills Research also issued estimates for NextPlat’s Q3 2026 earnings at $0.00 EPS, Q4 2026 earnings at $0.07 EPS, FY2026 earnings at ($0.55) EPS, Q1 2027 earnings at $0.10 EPS, Q2 2027 earnings at $0.14 EPS, Q3 2027 earnings at $0.16 EPS, Q4 2027 earnings at $0.17 EPS and FY2027 earnings at $0.57 EPS.

Separately, Weiss Ratings raised shares of NextPlat from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, May 11th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $11.00.

NextPlat Stock Up 3.0%

Shares of NASDAQ NXPL opened at $6.67 on Friday. NextPlat has a 12-month low of $3.38 and a 12-month high of $11.10. The firm’s 50-day simple moving average is $6.37 and its 200 day simple moving average is $5.93. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.05. The company has a market cap of $18.09 million, a price-to-earnings ratio of -1.55 and a beta of 1.90.

NextPlat (NASDAQ:NXPL) last issued its quarterly earnings data on Thursday, May 14th. The company reported ($0.42) earnings per share for the quarter. The firm had revenue of $9.86 million for the quarter. NextPlat had a negative return on equity of 58.05% and a negative net margin of 23.14%.

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned about 0.19% of NextPlat as of its most recent filing with the SEC. 1.30% of the stock is owned by institutional investors.

Trending Headlines about NextPlat

Here are the key news stories impacting NextPlat this week:

• Positive Sentiment: Litchfield Hills Research initiated coverage on NextPlat Corp. (NXPL) with a Buy rating and a $11.00 price target, signaling confidence in upside potential. Street Insider article
• Positive Sentiment: The analyst’s estimates for FY2027 call for $0.57 EPS, suggesting NextPlat could move into profitability over the longer term. Benzinga article
• Neutral Sentiment: Short interest fell in mid-June, but the latest update showed an unusual zero-share figure, so the signal is unclear and likely has limited immediate impact.
• Neutral Sentiment: The research note also includes mixed near-term EPS estimates, including a projected loss in FY2026, which tempers the bullish outlook.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.